{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:27Z","timestamp":1762431147127,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS070202","P50NS062684","R01NS065070"],"award-info":[{"award-number":["R21NS070202","P50NS062684","R01NS065070"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX000531"],"award-info":[{"award-number":["I01BX000531"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bastyr University","award":["Faculty Seed Grants #3 and #4 2009-2011"],"award-info":[{"award-number":["Faculty Seed Grants #3 and #4 2009-2011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00702-016-1590-x","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T07:36:19Z","timestamp":1467012979000},"page":"1319-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease"],"prefix":"10.1007","volume":"123","author":[{"given":"Paola","family":"Costa-Mallen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus P.","family":"Zabetian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ching","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinky","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Yearout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Checkoway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tibtech.2012.10.003","volume":"31","author":"AI Alayash","year":"2013","unstructured":"Alayash AI, Andersen CB, Moestrup SK, B\u00fclow L (2013) Haptoglobin: the hemoglobin detoxifier in plasma. Trends Biotechnol 31:2\u20133. doi:\n                    10.1016\/j.tibtech.2012.10.003","journal-title":"Trends Biotechnol"},{"key":"1590_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schr\u00f6der U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999\u20131005","journal-title":"Arch Neurol"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4615-8315-8_3","volume":"12","author":"BH Bowman","year":"1982","unstructured":"Bowman BH, Kurosky A (1982) Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 12:189\u2013261","journal-title":"Adv Hum Genet"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","volume":"116","author":"LA Cohen","year":"2010","unstructured":"Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, Sougrat R, Morgenstern A, Galy B, Hentze MW, Lazaro FJ, Rouault TA, Meyron-Holtz EG (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116:1574\u20131584. doi:\n                    10.1182\/blood-2009-11-253815","journal-title":"Blood"},{"key":"1590_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/mgme.2000.3015","volume":"71","author":"DE Comings","year":"2000","unstructured":"Comings DE, MacMurray JP (2000) Molecular heterosis: a review. Mol Genet Metab 71:19\u201331","journal-title":"Mol Genet Metab"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","volume":"65","author":"JR Connor","year":"1995","unstructured":"Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer\u2019s diseased brains. J Neurochem 65:717\u2013724","journal-title":"J Neurochem"},{"key":"1590_CR7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood.V48.3.449.449","volume":"48","author":"JD Cook","year":"1976","unstructured":"Cook JD, Finch CA, Smith NJ (1976) Evaluation of the iron status of a population. Blood 48:449\u2013455","journal-title":"Blood"},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ajmg.b.30593","volume":"147B","author":"P Costa-Mallen","year":"2008","unstructured":"Costa-Mallen P, Checkoway H, Zabeti A, Edenfield MJ, Swanson PD, Longstreth WT Jr, Franklin GM, Smith-Weller T, Sadrzadeh SM (2008) The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 147B:216\u2013222","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.parkreldis.2015.07.006","volume":"21","author":"P Costa-Mallen","year":"2015","unstructured":"Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H (2015) Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism Relat Disord 21:1087\u20131092. doi:\n                    10.1016\/j.parkreldis.2015.07.006","journal-title":"Parkinsonism Relat Disord"},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/379733a0","volume":"379","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733\u2013766","journal-title":"Nature"},{"key":"1590_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/jnnp.51.3.440","volume":"51","author":"N Fr\u00f6hlander","year":"1988","unstructured":"Fr\u00f6hlander N, Forsgren L (1988) Haptoglobin phenotype in motor neuron disease. J Neurol Neurosurg Psychiatry 51:440\u2013442","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1164\/rccm.200802-334OC","volume":"178","author":"AJ Ghio","year":"2008","unstructured":"Ghio AJ, Hilborn ED, Stonehuerner JG, Dailey LA, Carter JD, Richards JH, Crissman KM, Foronjy RF, Uyeminami DL, Pinkerton KE (2008) Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med 178:1130\u20131138. doi:\n                    10.1164\/rccm.200802-334OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1590_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/WNL.38.9.1402","volume":"38","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) A comparison of clinical and pathological features of young- and old- onset Parkinson\u2019s disease. Neurology 38:1402\u20131406","journal-title":"Neurology"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685\u2013716","journal-title":"Drugs Aging"},{"key":"1590_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJM197505012921805","volume":"292","author":"A Jacobs","year":"1975","unstructured":"Jacobs A, Worwood F (1975) Ferritin in serum. Clinical and biochemical implications. N Engl J Med 292:951\u2013956","journal-title":"N Engl J Med"},{"key":"1590_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1423-0410.1965.tb01396.x","volume":"10","author":"J Javid","year":"1965","unstructured":"Javid J (1965) The effect of haptoglobin-polymer size on hemoglobin binding capacity. Vox Sang 10:320\u2013325","journal-title":"Vox Sang"},{"key":"1590_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.parkreldis.2006.10.002","volume":"13","author":"D Koziorowski","year":"2007","unstructured":"Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D (2007) ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson\u2019s disease and incidental Lewy body compared to control. Parkinsonism Relat Disord 13:214\u2013218","journal-title":"Parkinsonism Relat Disord"},{"key":"1590_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","volume":"409","author":"M Kristiansen","year":"2001","unstructured":"Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198\u2013201","journal-title":"Nature"},{"key":"1590_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2169\/internalmedicine.45.1537","volume":"45","author":"C Kurata","year":"2006","unstructured":"Kurata C (2006) Medical check-up findings characteristic of smokers: aimed at improving smoking cessation interventions by physicians. Intern Med 45:1027\u20131032","journal-title":"Intern Med"},{"key":"1590_CR21","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","volume":"42","author":"MR Langlois","year":"1996","unstructured":"Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42:1589\u20131600","journal-title":"Clin Chem"},{"key":"1590_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/BF01024768","volume":"9","author":"DJ McCormick","year":"1990","unstructured":"McCormick DJ, Atassi MZ (1990) Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem 9:735\u2013742","journal-title":"J Protein Chem"},{"key":"1590_CR23","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","volume":"98","author":"M Melamed-Frank","year":"2001","unstructured":"Melamed-Frank M, Lache O, Enav BI, Szafrenek T, Levy NS, Ricklis RM, Levy AP (2001) Structure\u2013function analysis of the antioxidant properties of haptoglobin. Blood 98:3693\u20133698","journal-title":"Blood"},{"issue":"4","key":"1590_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/oxfordjournals.aje.a008941","volume":"144","author":"DM Morens","year":"1996","unstructured":"Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D (1996) Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson\u2019s disease. Am J Epidemiol 144(4):400\u2013404","journal-title":"Am J Epidemiol"},{"key":"1590_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2006.08.028","volume":"377","author":"CA Northrop-Clewes","year":"2007","unstructured":"Northrop-Clewes CA, Thurnham DI (2007) Monitoring micronutrients in cigarette smokers. Clin Chim Acta 377:14\u201338","journal-title":"Clin Chim Acta"},{"key":"1590_CR26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990\u2013997","journal-title":"Arch Neurol"},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.24012","volume":"27","author":"Nielsen S Searles","year":"2012","unstructured":"Searles Nielsen S, Gallagher LG, Lundin JI, Longstreth WT Jr, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H (2012) Environmental tobacco smoke and Parkinson\u2019s disease. Mov Disord 27:293\u2013296. doi:\n                    10.1002\/mds.24012","journal-title":"Mov Disord"},{"key":"1590_CR28","first-page":"119","volume":"10","author":"SV Torti","year":"1994","unstructured":"Torti SV, Torti FM (1994) Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10:119\u2013137","journal-title":"Adv Inorg Biochem"},{"key":"1590_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1750-3639.2009.00296.x","volume":"20","author":"D Tsuang","year":"2010","unstructured":"Tsuang D, Larson EB, Li G, Shofer JB, Montine KS, Thompson ML, Sonnen JA, Crane PK, Leverenz JB, Montine TJ (2010) Association between lifetime cigarette smoking and Lewy body accumulation. Brain Pathol 20:412\u2013418. doi:\n                    10.1111\/j.1750-3639.2009.0029.00296.x","journal-title":"Brain Pathol"},{"key":"1590_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00702-011-0664-z","volume":"119","author":"U Walter","year":"2012","unstructured":"Walter U, Witt R, Wolters A, Wittstock M, Benecke R (2012) Substantia nigra echogenicity in Parkinson\u2019s disease: relation to serum iron and C-reactive protein. J Neural Transm 119:53\u201357. doi:\n                    10.1007\/s00702-011-0664-z","journal-title":"J Neural Transm"},{"key":"1590_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","volume":"16","author":"A Wypijewska","year":"2010","unstructured":"Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, Jaklewicz A, Elbaum D, Friedman A (2010) Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 16:329\u2013333. doi:\n                    10.1016\/j.parkreldis.2010.02.007","journal-title":"Parkinsonism Relat Disord"},{"key":"1590_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MBH Youdim","year":"2004","unstructured":"Youdim MBH, Stephenson G, Ben Shachar D (2004) Ironing out iron in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators. A lesson from 6-hydroxydopamine and iron chelators desferal and VK-28. Ann NY Acad Sci 1012:306\u2013326","journal-title":"Ann NY Acad Sci"},{"key":"1590_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0952-8180(89)90079-2","volume":"1","author":"CJ Young","year":"1989","unstructured":"Young CJ, Moss J (1989) Smoke inhalation: diagnosis and treatment. J Clin Anesth 1:377\u2013386","journal-title":"J Clin Anesth"},{"key":"1590_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1212\/01.WNL.0000172630.22804.73","volume":"65","author":"CP Zabetian","year":"2005","unstructured":"Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A (2005) A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65:741\u2013744","journal-title":"Neurology"},{"key":"1590_CR36","doi-asserted-by":"publisher","first-page":"15819","DOI":"10.1523\/JNEUROSCI.3776-09.2009","volume":"29","author":"X Zhao","year":"2009","unstructured":"Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J (2009) Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 29:15819\u201315827. doi:\n                    10.1523\/JNEUROSCI.3776-09.2009","journal-title":"J Neurosci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-016-1590-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T08:06:53Z","timestamp":1589443613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-016-1590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s00702-016-1590-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"type":"print","value":"0300-9564"},{"type":"electronic","value":"1435-1463"}],"subject":[],"published":{"date-parts":[[2016,6,27]]},"assertion":[{"value":"12 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Costa-Mallen reports no conflict of interest and has been funded by grants from NIH and Bastyr University. Dr. Zabetian reports no conflict of interest and has been funded by grants from the American Parkinson Disease Association, Department of Veterans Affairs, NIH, the Parkinson\u2019s Disease Foundation, and a gift from the Dolsen Foundation. Dr. Shu-Ching Hu reports no conflict of interest and has been funded by grants from NIH. Dr. Agarwal reports no conflict of interest, she reports consulting for Teva Pharmaceutical, Cynapsus, US WorldMeds, UCB, Lundbeck, Impax, and has received research funding from the following companies and institutions: AbbVie Inc., Adamas, Amarantus Bioscience, Biotie, Astellas, Auspex, CHDI Foundation, Chelsea Therapeutic, Civitas, Cynapsus, EvergreenHealth, HSG, inVentive Health, Intec, Lunbeck, Massachusetts General Hospital, Merk & Co., Merz, NIH, Northwestern University, Omeros, Osmotica, Pfizer, PRA, PSG, Solstice, Teva, US WorldMeds. Dr. Checkoway reports no conflict of interest and has been consulting for Alcoa, Inc. (Pittsburgh), NIEHS, Exponent Corp (Los Angeles), Ohio State University, Electric Power Research Institute, (Palo Alto); he reports royalties from Elsevier Publishing Co. and Oxford University Press, and has been funded by grants from NIEHS and the National Multiple Sclerosis Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involved in human participants were in accordance with the ethical standards of the institution and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}